Back to Trades
Rao Raghu
Chief Executive OfficerDirectorCIK 0001806689
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025
Rao Raghu, Chief Executive Officer, Director, has filed 2 SEC reports (2025), all concentrated in Sonnet BioTherapeutics Holdings, Inc. (SONN), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.